Raanan Berger

Spécialisation: Radiation oncologist
27 années d'expérience
Parle:
English, Hebrew, Russian
Consultations en ligne : disponibles
Espace de travail: Israël, Ramat Gan, Centre médical Sheba
Inclus dans la liste des « Meilleurs médecins » de Forbes Israël (2025).
Le Dr Raanan Berger est directeur du centre de cancérologie du Sheba Medical Center. Il a été classé parmi les « Meilleurs médecins » par Forbes Israël en 2025. Le Dr Berger est spécialisé en oncologie génito-urinaire et traite les tumeurs complexes de la prostate par radiothérapie. Il a effectué un stage postdoctoral au Dana-Farber/Harvard Cancer Institute.
- Dirige l'unité de recherche clinique axée sur l'oncologie moléculaire.
- Co-auteur de plus de 20 articles évalués par des pairs sur le cancer de la prostate et les mutations BRCA.
- Membre de l'American Society of Clinical Oncology (ASCO).
- Pratique la thérapie systémique et la radiothérapie dans un hôpital classé parmi les 10 meilleurs au monde.

Consultation en ligne avec Raanan Berger

Pratique et facile

100 % sécurisé et confidentiel

$650

Où en sommes-nous ?

1 de 3

Les détails sur ce médecin sont exhaustifs et clairs

Fortement en désaccord

Fortement d’accord

Qualifications

Prof. Raanan Berger is a medical oncologist and radiotherapist at Sheba Medical Center. He serves as the Director of the Cancer Center and heads the clinical research unit. Prof. Berger was recognized in the 2025 Forbes Israel’s “Best Doctors” list.

Oncology Specialization and Approach

Prof. Berger leads the genitourinary oncology program with a primary focus on prostate cancer. He integrates systemic therapy and radiotherapy into a multidisciplinary care model. This approach combines medical treatment with psychological and social support for families. This lets patients receive emotional guidance throughout the process.

The doctor also treats a translational research laboratory. He investigates the molecular mechanisms that drive prostate and breast cancer development. His clinical work includes personalized treatment plans using neuroendoscopic methods for various genitourinary cancers. This work helps identify new ways to treat cancer.

Research and Scientific Contributions

Prof. Berger has co-authored over 20 peer-reviewed scientific publications. His research highlights include:

Classification studies of high-risk versus very high-risk prostate cancer
Outcomes of radiotherapy combined with androgen deprivation therapy
Research on inherited BRCA1 and BRCA2 mutations in large international cohorts
Study of molecular oncology and tumorigenesis mechanisms

Professional Experience

Director of the Cancer Center, Sheba Medical Center
Head of the Clinical Research Unit, Institute of Oncology and Radiotherapy
Lead of the Genitourinary Oncology Program, Sheba Medical Center

Education and Training

MD and PhD – School of Medicine, Tel Aviv University, Israel
Clinical training in Medical Oncology and Radiotherapy – Sheba Medical Center
Postdoctoral fellowship – Dana-Farber Cancer Institute, Harvard Medical School

During his Harvard fellowship, he focused on prostate cancer treatment with Dr. Philip Kantoff. He also conducted molecular oncology research in the laboratory of Dr. William C. Hahn. This research investigates the genetic causes of tumor growth.

Certifications and Memberships

Board Certified in Oncology
European Society for Medical Oncology (ESMO)
American Society of Clinical Oncology (ASCO)

Raanan Berger

Consultation en ligne avec Raanan Berger

Services du médecin